NBY News and Press, NovaBay Pharmaceuticals Inc. From 12/14/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday! Moving stocks this morning are earnings reports, de...

Douyin, China’s TikTok counterpart, drives 26% increase in DERMAdoctor sales and 258% more visitors to its online stores during Double 11 event NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the expansion of its lifestyle promotional vide...

NovaBay Pharmaceuticals ( NYSE: NBY ) announced that the company’s common stock would start trading on a split-adjusted basis on Nov. 15 after the closing bell following a 1-for-35 reverse stock split. Accordingly, every 35 shares of NBY’s outstanding common ...

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2022 Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Confer...

NovaBay press release ( NYSE: NBY ): Q3 GAAP EPS of -$0.10. Revenue of $3.83M (+68.7% Y/Y) NovaBay had cash and cash equivalents of $3.9 million as of September 30, 2022, compared with $7.5 million as of December 31, 2021. For further details see: NovaBay GAA...

NovaBay ( NYSE: NBY ) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close. The consensus EPS Estimate is -$0.03 (+40.0% Y/Y) and the consensus Revenue Estimate is $3.74M (+103.3% Y/Y). Over the last 3 months, EPS estimates have see...

New super-charged serum helps men and women minimize the size of enlarged facial pores NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the newest addition to the DERMAdoctor ® Picture Porefect ® collection: 15% Niacinamide ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present a company overview at the LD Micro Main Event XV ...

A California-based %Biotech company turned heads Tuesday in early trading after the company announced that it secured ‘significant’ orders for their %DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E. This news made traders ea...

NovaBay Pharmaceuticals ( NYSE: NBY ) on Tuesday said it received significant orders for DERMAdoctor Kakadu C anti-aging serum ahead of the holiday season. "These orders will favorably impact DERMAdoctor’s revenue contribution for the 2022 third and fourth ...